Clinical trials

  • ADX-038 for Geographic atrophy secondary to age-related macular degeneration
  • TENECTEPLASE for Acute ischemic stroke
  • ABEMACICLIB for Hormone receptor-positive, HER2-negative breast cancer at high risk of recurrence
  • LEVOSIMENDAN for Pulmonary hypertension | Heart failure with preserved ejection fraction (HFpEF)
  • CALCIFEDIOL for Pulmonary arterial hypertension
  • IZALONTAMAB BRENGITECAN for Metastatic urothelial cancer
  • PSILOCYBINE for Major depressive disorder
  • Propylene glycol for Atopic Dermatitis
  • TAMOXIFEN for Breast cancer
  • Rilvegostomig for Advanced solid tumors
  • ISONIAZID, RIFAMPICIN for Pulmonary tuberculosis | Community-acquired bacterial pneumonia
  • DNS-6288 for Catecholaminergic polymorphic ventricular tachycardia